Name | Relationship | Address | Signature | Signature date | CIK |
---|---|---|---|---|---|
Wai Conrad | CEO, Counterpart Health | C/O CLOVER HEALTH INVESTMENTS, CORP., NOT APPLICABLE, WILMINGTON | /s/ Peter J. Rivas as attorney-in-fact for Conrad Wai | 2025-06-17 | 0001971702 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | CLOV | Class A Common Stock | Tax liability | -$284K | -98.4K | -3.04% | $2.89 | 3.14M | Jun 14, 2025 | Direct | F1 |
Id | Content |
---|---|
F1 | Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations upon the vesting, on June 14, 2025, of 6.25% of the original number of time-based restricted stock units ("RSUs") granted to the Reporting Person on March 14, 2022. The remaining RSUs vest quarterly in equal installments of 6.25%, with a final vesting date occurring on March 14, 2026, subject to the continued service of the Reporting Person on each such vesting date. |